SCA: Interim Report Q1 2014

  SCA: Interim Report Q1 2014

Business Wire

STOCKHOLM -- April 29, 2014

Regulatory News:

SCA (Svenska Cellulosa AB) (STO:SCAA) (STO:SCAB)

JANUARY 1–MARCH 31, 2014 (compared with same period a year ago)

· Net sales rose 4% (9% excluding divestments) to SEK 24,234m (23,332)

· Operating profit, excluding items affecting comparability, rose 14% (18%
excluding exchange rate effects and divestments) to SEK 2,630m (2,315)

· Profit before tax, excluding items affecting comparability, rose 15% (19%
excluding exchange rate effects and divestments) to SEK 2,342m (2,036)

· Items affecting comparability totaled SEK -247m (-418)

· Earnings per share were SEK 2.12 (1.59)

· Cash flow from current operations was SEK 667m (1,385)

· Recalculations have been made for previous periods on account of new and
amended IFRSs and rules governing consolidated financial statements and joint
arrangements (see note 6)

(Table included in attached pdf at:
http://news.cision.com/sca/r/interim-report-q1-2014,c9576143)

CEO’S COMMENTS

The comparison of the first quarter of 2014 with the corresponding period
previous year was affected by the divestments of Laakirchen and some
Georgia-Pacific units and the acquisition of the majority shareholding in the
Chinese company Vinda.

The efficiency programs in the hygiene and forest products operations are
continuing according to plan.

Consolidated net sales for the first quarter of 2014, excluding divestments,
rose 9% compared with the same period a year ago. The increase is related to
the acquisition of the majority shareholding in the Chinese company Vinda,
higher volumes and higher prices.

In emerging markets, growth, excluding exchange rate effects, remains
favorable. The harsh winter in North America had a negative impact on demand
and earnings for AfH tissue.

Operating profit, excluding items affecting comparability, exchange rate
effects and divestments, rose 18%. The acquisition in China, cost savings,
higher volumes and higher prices contributed to earnings growth. Operating
profit for Personal Care, excluding items affecting comparability and exchange
rate, effects decreased by 6% as a result of higher raw material costs,
investments in increased marketing activities and negative transaction
exchange rate effects associated with weakened currencies in emerging markets.
Operating profit for Tissue, excluding items affecting comparability, exchange
rate effects and divestments, rose 14% as a result of the acquisition in
China, higher volumes, higher prices, cost savings and lower raw material and
energy costs. Operating profit for Forest Products, excluding items affecting
comparability and the divestment, rose 140% as a result of higher prices,
higher volumes, cost savings and lower energy costs.

Profit before tax excluding items affecting comparability, exchange rate
effects and divestments rose 19%.

NB

SCA discloses the information provided herein pursuant to the Securities
Markets Act. This report has been prepared in both Swedish and English
versions. In case of variations in the content between the two versions, the
Swedish version shall govern. Submitted for publication on April 29, 2014, at
8.00 CET. This report has not been reviewed by the company’s auditors.

This information was brought to you by Cision http://news.cision.com

Contact:

SCA
Johan Karlsson
Vice President Investor Relations, Group Function Communication
+46 8 788 51 30
or
Boo Ehlin
Vice President Media Relations, Group Function Communications
+46 8 788 51 36
or
Joséphine Edwall-Björklund
Senior Vice President, Group Function Communications
+46 8 788 52 34
 
Press spacebar to pause and continue. Press esc to stop.